These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 21493143)

  • 1. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease.
    Zepp J; Wu L; Li X
    Trends Immunol; 2011 May; 32(5):232-9. PubMed ID: 21493143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RKIP mediates autoimmune inflammation by positively regulating IL-17R signaling.
    Lin W; Wang N; Zhou K; Su F; Jiang Y; Shou J; Liu H; Ma C; Qian Y; Wang K; Wang X
    EMBO Rep; 2018 Jun; 19(6):. PubMed ID: 29674348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17 induced NOTCH1 activation in oligodendrocyte progenitor cells enhances proliferation and inflammatory gene expression.
    Wang C; Zhang CJ; Martin BN; Bulek K; Kang Z; Zhao J; Bian G; Carman JA; Gao J; Dongre A; Xue H; Miller SD; Qian Y; Hambardzumyan D; Hamilton T; Ransohoff RM; Li X
    Nat Commun; 2017 May; 8():15508. PubMed ID: 28561022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.
    Qian Y; Liu C; Hartupee J; Altuntas CZ; Gulen MF; Jane-Wit D; Xiao J; Lu Y; Giltiay N; Liu J; Kordula T; Zhang QW; Vallance B; Swaidani S; Aronica M; Tuohy VK; Hamilton T; Li X
    Nat Immunol; 2007 Mar; 8(3):247-56. PubMed ID: 17277779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling.
    Liu C; Qian W; Qian Y; Giltiay NV; Lu Y; Swaidani S; Misra S; Deng L; Chen ZJ; Li X
    Sci Signal; 2009 Oct; 2(92):ra63. PubMed ID: 19825828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of IL-17 receptor signaling and tissue inflammation by the p38α-MKP-1 signaling axis in a mouse model of multiple sclerosis.
    Huang G; Wang Y; Vogel P; Chi H
    Sci Signal; 2015 Mar; 8(366):ra24. PubMed ID: 25737586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis.
    Kang Z; Altuntas CZ; Gulen MF; Liu C; Giltiay N; Qin H; Liu L; Qian W; Ransohoff RM; Bergmann C; Stohlman S; Tuohy VK; Li X
    Immunity; 2010 Mar; 32(3):414-25. PubMed ID: 20303295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation and regulation of IL-17 receptor mediated signaling.
    Song X; Qian Y
    Cytokine; 2013 May; 62(2):175-82. PubMed ID: 23557798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
    Chung CY; Liao F
    J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
    Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
    Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes.
    Natarajan C; Bright JJ
    J Immunol; 2002 Jun; 168(12):6506-13. PubMed ID: 12055272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Carbajal KS; Mironova Y; Ulrich-Lewis JT; Kulkarni D; Grifka-Walk HM; Huber AK; Shrager P; Giger RJ; Segal BM
    J Immunol; 2015 Sep; 195(6):2552-9. PubMed ID: 26238492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E.
    Chang SH; Reynolds JM; Pappu BP; Chen G; Martinez GJ; Dong C
    Immunity; 2011 Oct; 35(4):611-21. PubMed ID: 21982598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12-polarized Th1 cells produce GM-CSF and induce EAE independent of IL-23.
    Grifka-Walk HM; Giles DA; Segal BM
    Eur J Immunol; 2015 Oct; 45(10):2780-6. PubMed ID: 26220255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Fletcher JM; Lalor SJ; Sweeney CM; Tubridy N; Mills KH
    Clin Exp Immunol; 2010 Oct; 162(1):1-11. PubMed ID: 20682002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 Cells and autoimmune encephalomyelitis (EAE/MS).
    Aranami T; Yamamura T
    Allergol Int; 2008 Jun; 57(2):115-20. PubMed ID: 18427164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.